Longyi blood glucose test system - Taiwan Registration 40856a5d717555f06006d0b1f530212a
Access comprehensive regulatory information for Longyi blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 40856a5d717555f06006d0b1f530212a and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is DRAGON PHARMACEUTICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory, Taibo Technology Co., Ltd. five-stock factory, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
40856a5d717555f06006d0b1f530212a
DHY00500330200
Product Details
This product provides a quantitative blood glucose test, which is suitable for diabetic patients to self-measure blood sugar or medical professionals to measure blood sugar. This system is suitable for fresh microvascular blood for blood glucose detection.
A Clinical chemistry and clinical toxicology
A.1345 Glucose Test System
Domestic;; Contract manufacturing
Dates and Status
Jun 24, 2011
Jun 24, 2016
Aug 17, 2016
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ
Longyi blood glucose test system
Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory
63e6f84aa9c15a2221135eb828d00c52
2
Longyi blood glucose test system
Taibo Technology Co., Ltd. five-stock factory
d3ab31442de986d6077f83dc895ba08f
2